Back

Loss of STARD7 Impairs Mitochondrial Phospholipid Homeostasis and Contributes to Mitochondrial Myopathy

Horibata, Y.; Sato, T.; Ohyama, M.; Yuyama, S.; Itoh, M.; Miura, S.; Konishi, A.; Sugimoto, H.

2025-11-30 biochemistry
10.1101/2025.11.27.691062 bioRxiv
Show abstract

Mitochondria are composed of phospholipid bilayers rich in phosphatidylcholine (PC). StAR-related lipid transfer domain-containing protein 7 (STARD7) functions as a lipid transfer protein that plays a crucial role in maintaining mitochondrial PC homeostasis. In this study, we investigated the physiological role of STARD7 in skeletal muscle using muscle-specific knockout (mKO) mice. STARD7 expression was markedly higher in the soleus, a mitochondria-dense slow-twitch muscle, compared with fast-twitch fibers. Although muscle fibers from mKO mice exhibited no apparent structural abnormalities, their endurance exercise capacity was markedly reduced. RNA-seq analysis revealed suppressed expression of fast-twitch-related genes accompanied by a reduction in fast-twitch fibers. At the mitochondrial level, respiratory chain complexes remained intact, but oxygen consumption was consistently decreased. Targeted lipidomic analysis showed decreased levels of PC, cardiolipin (CL), and coenzyme Q in mKO mitochondria, particularly in the soleus. Conversely, expression of CL biosynthetic enzymes was unchanged, and an in vitro binding assay indicated that STARD7 preferentially transfers linoleic acid-containing PC required for CL remodeling. Furthermore, electron microscopy revealed disorganized cristae structures, whereas 4-HNE-modified proteins, mtDNA content, and OPA1 processing remained unaffected. Together, these findings demonstrate that STARD7 plays an essential role for maintaining mitochondrial integrity and function in skeletal muscle, and its loss likely contributes to the pathogenesis of mitochondrial myopathy.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Journal of Cachexia, Sarcopenia and Muscle
27 papers in training set
Top 0.1%
23.0%
2
Aging Cell
144 papers in training set
Top 0.8%
7.3%
3
The FASEB Journal
175 papers in training set
Top 0.1%
4.9%
4
American Journal of Physiology-Cell Physiology
34 papers in training set
Top 0.1%
3.7%
5
Circulation Research
39 papers in training set
Top 0.4%
3.1%
6
Journal of Biological Chemistry
641 papers in training set
Top 0.7%
3.1%
7
eLife
5422 papers in training set
Top 30%
2.9%
8
Journal of Cellular Physiology
21 papers in training set
Top 0.1%
2.5%
50% of probability mass above
9
PLOS ONE
4510 papers in training set
Top 46%
2.4%
10
Free Radical Biology and Medicine
33 papers in training set
Top 0.1%
2.1%
11
Scientific Reports
3102 papers in training set
Top 53%
1.9%
12
International Journal of Molecular Sciences
453 papers in training set
Top 6%
1.9%
13
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.3%
1.8%
14
Molecular Therapy - Nucleic Acids
24 papers in training set
Top 0.1%
1.8%
15
Disease Models & Mechanisms
119 papers in training set
Top 1%
1.7%
16
Nature Communications
4913 papers in training set
Top 51%
1.7%
17
Frontiers in Physiology
93 papers in training set
Top 3%
1.5%
18
Redox Biology
64 papers in training set
Top 0.5%
1.4%
19
Journal of Clinical Investigation
164 papers in training set
Top 4%
1.2%
20
iScience
1063 papers in training set
Top 21%
1.2%
21
Journal of the American Heart Association
119 papers in training set
Top 3%
1.1%
22
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
25 papers in training set
Top 0.6%
1.0%
23
Cell Death Discovery
51 papers in training set
Top 1%
0.9%
24
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 7%
0.9%
25
Cell Reports
1338 papers in training set
Top 30%
0.9%
26
Molecular Metabolism
105 papers in training set
Top 1%
0.9%
27
Mitochondrion
11 papers in training set
Top 0.1%
0.9%
28
Human Molecular Genetics
130 papers in training set
Top 3%
0.8%
29
JCI Insight
241 papers in training set
Top 6%
0.8%
30
Communications Biology
886 papers in training set
Top 23%
0.8%